The results indicated that the mRNA expression of KMO was significantly higher in invasive ductal breast carcinoma, invasive lobular breast carcinoma, lobular breast carcinoma, invasive breast carcinoma, and ductal breast carcinoma in situ compared with matched normal tissues. The gene discussed is KMO; the disease is ductal breast carcinoma in situ.